These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 114649

  • 21. Treatment of rheumatoid arthritis with gold.
    Liang GC.
    Wis Med J; 1978 Aug; 77(8):S71-2. PubMed ID: 99882
    [No Abstract] [Full Text] [Related]

  • 22. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG, Morgan SH, Parke AL, Childs L, Goldman M, Hughes GR.
    Int J Clin Pharmacol Res; 1984 Aug; 4(6):395-401. PubMed ID: 6442711
    [Abstract] [Full Text] [Related]

  • 23. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
    Davis P, Landon M.
    J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724
    [No Abstract] [Full Text] [Related]

  • 24. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC, Osborn TG.
    Clin Pharm; 1984 Jun; 3(2):121-7. PubMed ID: 6426843
    [Abstract] [Full Text] [Related]

  • 25. [The detection of gold atoms in lymphocyte and erythrocyte chromatin following therapy with 2 different gold compounds in patients with chronic polyarthritis].
    Bröll H, Tausch G, Teherani DK.
    Wien Klin Wochenschr Suppl; 1984 Jun; 156():16. PubMed ID: 6442049
    [No Abstract] [Full Text] [Related]

  • 26. [Gold therapy of rheumatic diseases].
    Berndt H.
    Z Arztl Fortbild (Jena); 1987 Jun; 81(9):416. PubMed ID: 3114970
    [No Abstract] [Full Text] [Related]

  • 27. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE, Roisman FR, Batista V, de Nudelman FG, de Titto EH, Mizraji M, Walz DT.
    J Rheumatol; 1980 Jun; 7(2):160-8. PubMed ID: 6768887
    [Abstract] [Full Text] [Related]

  • 28. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M, Kaik B, Muller-Fassbender H, Rau R, Zeidler H.
    J Rheumatol Suppl; 1982 Jun; 8():184-9. PubMed ID: 6813483
    [Abstract] [Full Text] [Related]

  • 29. The mechanisms of action of conventional chrysotherapy.
    Bluhm GB.
    J Rheumatol Suppl; 1982 Jun; 8():10-7. PubMed ID: 6813472
    [Abstract] [Full Text] [Related]

  • 30. Comparative pharmacokinetics of parenteral and oral gold compounds.
    Gottlieb NL.
    J Rheumatol Suppl; 1982 Jun; 8():99-109. PubMed ID: 6813498
    [Abstract] [Full Text] [Related]

  • 31. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW, Ludvigsen NW, Cleland LG, Milazzo SC.
    J Rheumatol; 1982 Jun; 9(4):532-5. PubMed ID: 6813469
    [Abstract] [Full Text] [Related]

  • 32. Gold distribution in whole blood during chrysotherapy.
    Smith PM, Smith EM, Gottlieb NL.
    J Lab Clin Med; 1973 Dec; 82(6):930-7. PubMed ID: 4202278
    [No Abstract] [Full Text] [Related]

  • 33. Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis.
    Berglöf FE, Berglöf K, Walz DT.
    J Rheumatol; 1978 Dec; 5(1):68-74. PubMed ID: 641915
    [Abstract] [Full Text] [Related]

  • 34. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O, Smolen JS, Mayr WR, Mayrhofer F, Kolarz G, Thumb NJ.
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [Abstract] [Full Text] [Related]

  • 35. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M, Keown PA, Orange J.
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [Abstract] [Full Text] [Related]

  • 36. Chrysotherapy-induced aplastic anemia: a case report.
    Shearer CA, Parker WA.
    Am J Hosp Pharm; 1978 Sep; 35(9):1095-9. PubMed ID: 100010
    [Abstract] [Full Text] [Related]

  • 37. [Indications and contraindications for systemic gold therapy].
    Schattenkirchner M.
    Wien Klin Wochenschr Suppl; 1984 Sep; 156():3-7. PubMed ID: 6442054
    [Abstract] [Full Text] [Related]

  • 38. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
    Lorber A, Kunishima DH, Harralson AF, Simon TM.
    J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
    [Abstract] [Full Text] [Related]

  • 39. Gold in the dermis following gold therapy for rheumatoid arthritis.
    Cox AJ, Marich KW.
    Arch Dermatol; 1973 Nov; 108(5):655-7. PubMed ID: 4201477
    [No Abstract] [Full Text] [Related]

  • 40. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy.
    Luukkainen R.
    Scand J Rheumatol Suppl; 1980 Nov; 34():1-56. PubMed ID: 6791272
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.